Related references
Note: Only part of the references are listed.Engineered Nanoparticle Applications for Recombinant Influenza Vaccines
Zachary R. Sia et al.
MOLECULAR PHARMACEUTICS (2021)
Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity
Ji Wang et al.
SCIENCE (2020)
Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases
Lev A. Dykman
EXPERT REVIEW OF VACCINES (2020)
Polyethylenimine based magnetic nanoparticles mediated non-viral CRISPR/Cas9 system for genome editing
S. S. Rohiwal et al.
SCIENTIFIC REPORTS (2020)
In vivo pharmacokinetics, transfer and clearance study of graphene oxide by La/Ce dual elemental labelling method
Shanshan Liang et al.
NANOIMPACT (2020)
Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections
Cynthia Calzas et al.
FRONTIERS IN IMMUNOLOGY (2019)
Protective Antibodies Against Influenza Proteins
Herbey O. Padilla-Quirarte et al.
FRONTIERS IN IMMUNOLOGY (2019)
The human antibody response to influenza A virus infection and vaccination
Florian Krammer
NATURE REVIEWS IMMUNOLOGY (2019)
Polyethylenimine-Modified Fluorescent Carbon Dots As Vaccine Delivery System for Intranasal Immunization
Sha Li et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)
Polyethylenimine-Modified Fluorescent Carbon Dots As Vaccine Delivery System for Intranasal Immunization
Sha Li et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)
Gold nanoparticles conjugating recombinant influenza hemagglutinin trimers and flagellin enhanced mucosal cellular immunity
Chao Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses
Lei Deng et al.
NATURE COMMUNICATIONS (2018)
Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture
Daniela S. Rajao et al.
FRONTIERS IN MICROBIOLOGY (2018)
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
Yu-Li Lin et al.
SCIENTIFIC REPORTS (2018)
Composites of Proteins and 2D Nanomaterials
Melik C. Demirel et al.
ADVANCED FUNCTIONAL MATERIALS (2018)
Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity
Li Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery
Katelyn T. Gause et al.
ACS NANO (2017)
Carbohydrate-Functionalized rGO as an Effective Cancer Vaccine for Stimulating Antigen-Specific Cytotoxic T Cells and Inhibiting Tumor Growth
Arjyabaran Sinha et al.
CHEMISTRY OF MATERIALS (2017)
Spontaneous Protein Adsorption on Graphene Oxide Nanosheets Allowing Efficient Intracellular Vaccine Protein Delivery
Hui Li et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Graphene Oxides Decorated with Carnosine as an Adjuvant To Modulate Innate Immune and Improve Adaptive Immunity in Vivo
Chunchun Meng et al.
ACS NANO (2016)
Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
Nicole L. Kallewaard et al.
CELL (2016)
Noncovalent Functionalization of Graphene and Graphene Oxide for Energy Materials, Biosensing, Catalytic, and Biomedical Applications
Vasilios Georgakilas et al.
CHEMICAL REVIEWS (2016)
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
David J. DiLillo et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity
Ligeng Xu et al.
NANOSCALE (2016)
Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
Hok Hei Tam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Exploration of graphene oxide as an intelligent platform for cancer vaccines
Hua Yue et al.
NANOSCALE (2015)
Biodistribution of a High Dose of Diamond, Graphite, and Graphene Oxide Nanoparticles After Multiple Intraperitoneal Injections in Rats
Natalia Kurantowicz et al.
NANOSCALE RESEARCH LETTERS (2015)
Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus
Tadaki Suzuki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Antonietta Impagliazzo et al.
SCIENCE (2015)
Dispersibility-Dependent Biodegradation of Graphene Oxide by Myeloperoxidase
Rajendra Kurapati et al.
SMALL (2015)
Biodistribution of a High Dose of Diamond, Graphite, and Graphene Oxide Nanoparticles After Multiple Intraperitoneal Injections in Rats
Natalia Kurantowicz et al.
NANOSCALE RESEARCH LETTERS (2015)
Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization
Catherine A. Fromen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Ultrasmall Graphene Oxide Supported Gold Nanoparticles as Adjuvants Improve Humoral and Cellular Immunity in Mice
Yuhua Cao et al.
ADVANCED FUNCTIONAL MATERIALS (2014)
Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines
Li Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
Julia Scheiermann et al.
VACCINE (2014)
In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration
Kai Yang et al.
BIOMATERIALS (2013)
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Masaru Kanekiyo et al.
NATURE (2013)
Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets
Yusong Tu et al.
NATURE NANOTECHNOLOGY (2013)
Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers
Robert J. Hopkins et al.
VACCINE (2013)
Mucosal Vaccine Design and Delivery
Kim A. Woodrow et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 14 (2012)
Mucosal immunity and nasal influenza vaccination
Markus A. Rose et al.
EXPERT REVIEW OF VACCINES (2012)
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens
Frank Wegmann et al.
NATURE BIOTECHNOLOGY (2012)
Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection
Suzanne E. Ohmit et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Graphene based gene transfection
Liangzhu Feng et al.
NANOSCALE (2011)
Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers
Dianna Rynkiewicz et al.
VACCINE (2011)
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
Tomonori Nochi et al.
NATURE MATERIALS (2010)
Enhanced Immunogenicity of Stabilized Trimeric Soluble Influenza Hemagglutinin
William C. Weldon et al.
PLOS ONE (2010)
Effective collaboration between IL-4 and IL-21 on B cell activation
Toru Saito et al.
IMMUNOBIOLOGY (2008)
Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation
Sven Burgdorf et al.
NATURE IMMUNOLOGY (2008)
Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study
Craig A. Poland et al.
NATURE NANOTECHNOLOGY (2008)
The known unknowns of antigen processing and presentation
Jatin M. Vyas et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity
Arthur M. Krieg et al.
IMMUNOLOGICAL REVIEWS (2007)
Generation of improved mucosal vaccines by induction of innate immunity
EC Lavelle
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus
Y Asahi-Ozaki et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Share Paper
